focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQE Regulatory News (IQE)

Share Price Information for IQE (IQE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 35.10
Bid: 34.85
Ask: 35.20
Change: -1.05 (-2.90%)
Spread: 0.35 (1.004%)
Open: 37.00
High: 37.00
Low: 34.95
Prev. Close: 36.15
IQE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

4 Jun 2018 07:00



AGM Statement



AGM Statement


4 June 2018

IQE plc (AIM: IQE, "IQE" or the "Group") the leading global supplier of advanced semiconductor wafer products and services to the semiconductor industry, announces that at its Annual General Meeting which will be held at 11:00 today, Godfrey Ainsworth, Executive Chairman of IQE will make the following statement:

“In our 2017 results announcement and Annual Report and Accounts, we stated that we would use H1 2018 to replenish wireless inventory channels which had been depleted as a consequence of the rapid ramp of VCSELs in H2 2017 and that photonics capacity would be released to qualify multiple other customers for VCSELs in H1 2018. We are pleased to confirm strong wireless activity and that we are actively engaged in VCSEL qualification programmes with over 10 additional key VCSEL chip manufacturers, which are progressing in line with the board’s expectations. We confirm our guidance for a 40:60 revenue split H1:H2 2018, with a shift back from wireless to photonics as we enter H2 2018.

“The commissioning of the new Newport Foundry is progressing to plan, with the first five reactors now all on site and in various stages of acceptance testing, commissioning and qualification. The second five reactors are expected to be delivered on site commencing Q3 2018, with acceptance testing, commissioning and qualification during the rermainder of 2018.

“Our new technologies portfolio, including GaN on Silicon, NanoImprint Lithography (NIL), Crystalline Rare Earth Oxide (cREO), and Quasi Photonic Crystals (QPC), is rapidly gaining strong traction and engagement with key customers around the globe for a wide variety of high volume applications.”

“On the Corporate front, following the tragic death of Mr Phillip Rasmussen ACA, the Group’s CFO in April, 2018, the Board appointed Dr Godfrey Ainsworth FCA, as Executive Chairman of the Group with immediate effect and he has been retained on a one year contract running to 31st March 2019. As previously announced, Dr Ainsworth will provide investor relations support to the CEO Dr Drew Nelson, and oversight to the Group Finance team, headed by Group Finance Director, Mr Neil Rummings ACA. The Board is also actively engaged with head-hunters to recruit a replacement permanent CFO. The Nominations Committee is also working to recruit an additional Non-executive Director who will take over the Chair of the Audit Committee, which in the interim period, is chaired by Sir Derek Jones. Dr Ainsworth has also indicated to the Board that once all candidates have been appointed to these roles, he will seek to retire at the end of his one year contract. Mr Phil Smith, former Chairman of Cisco who joined the board in December 2016, will become Non-executive Chairman on the retirement of Dr Ainsworth.”

The Group will announce its Interim Results for the six months ended 30 June 2018 on Tuesday, 4th September 2018. An analyst briefing will be held later that day at a time and venue to be announced.

Contacts:

IQE plc Dr Godfrey Ainsworth Dr Drew Nelson Chris Meadows +44 (0) 29 2083 9400
Canaccord Genuity Simon Bridges Henry Fitzgerald-O'Connor Richard Andrews   + 44 (0) 20 7523 8000
Peel Hunt Edward Knight Nick Prowting +44 (0) 20 7418 8900



© 2018 GlobeNewswire, Inc. All rights reserved.




Date   Source Headline
5th Jun 20132:22 pmRNSMerger Update
8th Mar 20133:00 pmRNSMerger Update
8th Jan 20138:39 amRNSStatement regarding press articles
31st Jul 20123:54 pmRNSDirectorate Change
10th Apr 20125:11 pmRNSDirector Dealings
27th Mar 20122:00 pmRNSPartnership Agreement
8th Feb 20124:10 pmRNSCompletion of Placing
17th Feb 20103:56 pmRNSNominated Adviser Change of Name
7th Aug 20094:42 pmRNSHolding(s) in Company
7th Aug 20094:30 pmRNSBondholders meeting
7th Aug 20093:51 pmRNSDirector Dealing in Shares
12th Jun 20081:42 pmRNSAdditional Listing
15th Apr 20087:01 amRNSAdditional Listing
7th Apr 200812:14 pmRNSDirector/PDMR Shareholding
28th Mar 200811:52 amRNSDirector/PDMR Shareholding
19th Mar 20087:00 amRNSDirector/PDMR Shareholding
17th Mar 20081:00 pmRNSContract Win
17th Mar 20087:01 amRNSFinal Results
28th Feb 20083:27 pmRNSHolding(s) in Company
19th Feb 20088:30 amRNSNotice of Results
25th Jan 20087:00 amRNSBank Facilities
17th Jan 20087:00 amRNSTrading Update
16th Jan 200811:15 amRNSBroker Appointment
15th Jan 200812:12 pmRNSDirector/PDMR Shareholding
9th Jan 20084:26 pmRNSAdditional Listing
7th Jan 20087:00 amRNSDirector/PDMR Shareholding
4th Jan 200812:46 pmRNSHolding(s) in Company
19th Dec 20077:30 amRNSAdditional Listing
18th Dec 20073:52 pmRNSSubstrate supply contract
13th Dec 20077:01 amRNSSuccessful Qualifications
9th Nov 200710:53 amRNSDirector/PDMR Shareholding
3rd Oct 200710:41 amRNSDirector/PDMR Shareholding
1st Oct 20072:44 pmRNSAdditional Listing
28th Sep 200710:14 amRNSContract Win
28th Sep 20078:12 amRNSInvestor Presentation
4th Sep 200712:03 pmRNSDirector/PDMR Shareholding
28th Aug 20072:17 pmRNSHolding(s) in Company
24th Aug 20073:36 pmRNSHolding(s) in Company
22nd Aug 20077:01 amRNSContract Win
22nd Aug 20077:01 amRNSInterim Results
15th Aug 20077:01 amRNSIFRS Transitional Stmnt - Amd
14th Aug 20077:01 amRNSIFRS Transitional Statement
13th Aug 20071:19 pmRNSRule 26 Compliance
2nd Aug 20078:39 amRNSResearch Consortium
1st Aug 20073:52 pmRNSNotice of Results
25th Jul 20071:35 pmRNSResult of AGM
11th Jul 20078:00 amRNSHolding(s) in Company
9th Jul 20077:00 amRNSTrading Statement
18th Jun 20073:35 pmRNSHolding(s) in Company
4th Jun 20074:15 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.